Dianthus Therapeutics (DNTH) Other Non Operating Income (2022 - 2025)
Dianthus Therapeutics' quarterly Other Non Operating Income came in at -$2000.0 in Q3 2025, down 109.09% year-on-year from $22000.0 in Q3 2024, and up 93.33% quarter-over-quarter from -$30000.0 in Q2 2025.
Dianthus Therapeutics has reported Other Non Operating Income for 4 years, with the latest figure at -$2000.0 in Q3 2025.
- For the quarter ending Q3 2025, Other Non Operating Income fell 109.09% year-over-year to -$2000.0; the trailing twelve-month figure through Sep 2025 stood at -$517000.0 (down 406.86% YoY), and the FY2024 full-year result was -$554000.0, down 551.76% from the prior year.
- Other Non Operating Income for Q3 2025 stood at -$2000.0, up from -$30000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $22000.0 in Q3 2024, with the low at -$463000.0 in Q4 2024.
- Average Other Non Operating Income over 4 years is -$66923.1, with a median of -$22000.0 recorded in 2025.
- Peak annual rise in Other Non Operating Income reached 246.67% in 2024, while the deepest fall reached 1346.88% in 2024.
- Tracing DNTH's Other Non Operating Income over 4 years: stood at -$208000.0 in 2022, then surged by 84.62% to -$32000.0 in 2023, then sank by 1346.88% to -$463000.0 in 2024, then soared by 99.57% to -$2000.0 in 2025.
- The last three Other Non Operating Income figures came in at -$2000.0 (Q3 2025), -$30000.0 (Q2 2025), and -$22000.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Dianthus Therapeutics | 4.02 Bn | 3.62 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -2,000.00 |
| Jun 30, 2025 | -30,000.00 |
| Mar 31, 2025 | -22,000.00 |
| Dec 31, 2024 | -463,000.00 |
| Sep 30, 2024 | 22,000.00 |
| Jun 30, 2024 | -80,000.00 |
| Mar 31, 2024 | -12,000.00 |
| Dec 31, 2023 | -32,000.00 |
| Sep 30, 2023 | -15,000.00 |
| Jun 30, 2023 | -23,000.00 |
| Mar 31, 2023 | -3,000.00 |
| Dec 31, 2022 | -208,000.00 |
| Sep 30, 2022 | -2,000.00 |